NDC properties for NDC 9 51759-363
NDC item 51759036322
NDC 9 | 51759-363 |
---|---|
NDC 10 | 51759-363-22 |
NDC Item | 51759036322 |
packaging | 2 KIT in 1 CARTON (51759-363-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-624-31) * .4 mL in 1 POUCH |
BLA | BLA761299 |
Labeler | Teva Pharmaceuticals USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2025-02-28 |
Marketing status | active |
NDC item 82009015822
NDC 9 | 82009-158 |
---|---|
NDC 10 | 82009-158-22 |
NDC Item | 82009015822 |
packaging | 2 KIT in 1 CARTON (82009-158-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-159-11) / .4 mL in 1 SYRINGE * .4 mL in 1 POUCH |
BLA | BLA761299 |
Labeler | Quallent Pharmaceuticals Health LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2024-07-31 |
Marketing status | ACTIVE |
NDC item 82009015911
NDC 9 | 82009-159 |
---|---|
NDC 10 | 82009-159-11 |
NDC Item | 82009015911 |
packaging | 0.4 mL in 1 SYRINGE |
packaging | 1 in 1 TRAY |
Labeler | Quallent Pharmaceuticals Health LLC |
Label type | HUMAN PRESCRIPTION DRUG LABEL |